Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)
44.57
-0.45 (-1.00%)
At close: Feb 13, 2026
SHE:301520 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 60.95 | 179.29 | 253.5 | 186.35 | 161.55 | 120.01 |
Trading Asset Securities | 1,101 | 1,023 | 902.81 | - | - | - |
Cash & Short-Term Investments | 1,162 | 1,203 | 1,156 | 186.35 | 161.55 | 120.01 |
Cash Growth | 1.78% | 4.02% | 520.52% | 15.35% | 34.61% | 244.24% |
Accounts Receivable | 176.02 | 176.48 | 135.09 | 92.68 | 57.88 | 41.05 |
Other Receivables | 7.03 | 3.99 | 3.24 | - | - | - |
Receivables | 183.06 | 180.47 | 138.33 | 92.68 | 57.88 | 41.05 |
Inventory | 0.96 | 1.96 | 0.67 | 0.44 | 0.18 | 0.38 |
Other Current Assets | 17.41 | 17.54 | 66.88 | 6.75 | 6.36 | 3 |
Total Current Assets | 1,363 | 1,403 | 1,362 | 286.22 | 225.97 | 164.45 |
Property, Plant & Equipment | 194.44 | 176.43 | 150.01 | 97.28 | 42.15 | 32.65 |
Long-Term Investments | 13 | 3 | - | - | - | - |
Other Intangible Assets | 10.85 | 11.57 | 12 | 10.09 | 9.48 | 0.79 |
Long-Term Deferred Tax Assets | 0.53 | - | 0.11 | 1.35 | 1 | 0.53 |
Long-Term Deferred Charges | 2.07 | 2.75 | 9.58 | 5.39 | 3.16 | 2.13 |
Other Long-Term Assets | 7.1 | 7.32 | 10.7 | 4.28 | 1.88 | - |
Total Assets | 1,591 | 1,604 | 1,545 | 404.6 | 283.63 | 200.55 |
Accounts Payable | 32.25 | 37.83 | 27.02 | 7.86 | 4.75 | 3.79 |
Accrued Expenses | 10 | 13.95 | 15.59 | 15.95 | 11.68 | 9.81 |
Short-Term Debt | 2.07 | 1.6 | 1 | - | - | - |
Current Portion of Leases | - | - | - | 0.03 | 0.12 | - |
Current Income Taxes Payable | 0.74 | 0.27 | 0.31 | 1.67 | 3.62 | 2.98 |
Current Unearned Revenue | 16.49 | 19.7 | 20.65 | 17.64 | 16.54 | 27.12 |
Other Current Liabilities | 0.82 | 1.36 | 2.36 | 22.1 | 7.57 | 0.72 |
Total Current Liabilities | 62.36 | 74.72 | 66.94 | 65.24 | 44.26 | 44.42 |
Long-Term Leases | - | - | - | - | 0.03 | - |
Long-Term Unearned Revenue | 10.34 | 7.41 | 6.55 | 2.94 | 2.95 | 1.96 |
Long-Term Deferred Tax Liabilities | 5.69 | 8.31 | 7.1 | 4.8 | 3.51 | 3.15 |
Total Liabilities | 78.39 | 90.44 | 80.58 | 72.98 | 50.75 | 49.53 |
Common Stock | 66.67 | 66.67 | 66.67 | 50 | 50 | 50 |
Additional Paid-In Capital | 1,039 | 1,037 | 1,037 | 29.79 | 29.79 | 29.79 |
Retained Earnings | 422.02 | 412.12 | 359.92 | 251.83 | 153.1 | 71.23 |
Treasury Stock | -15.23 | -2.84 | - | - | - | - |
Total Common Equity | 1,513 | 1,513 | 1,464 | 331.62 | 232.88 | 151.01 |
Shareholders' Equity | 1,513 | 1,513 | 1,464 | 331.62 | 232.88 | 151.01 |
Total Liabilities & Equity | 1,591 | 1,604 | 1,545 | 404.6 | 283.63 | 200.55 |
Total Debt | 2.07 | 1.6 | 1 | 0.03 | 0.15 | - |
Net Cash (Debt) | 1,160 | 1,201 | 1,155 | 186.32 | 161.41 | 120.01 |
Net Cash Growth | 1.60% | 3.97% | 520.08% | 15.43% | 34.49% | 244.24% |
Net Cash Per Share | 17.41 | 17.98 | 21.38 | 3.72 | 3.23 | 2.51 |
Filing Date Shares Outstanding | 66.26 | 66.67 | 66.67 | 50 | 49.92 | 50 |
Total Common Shares Outstanding | 66.26 | 66.67 | 66.67 | 50 | 49.92 | 50 |
Working Capital | 1,301 | 1,328 | 1,295 | 220.97 | 181.71 | 120.02 |
Book Value Per Share | 22.83 | 22.70 | 21.96 | 6.63 | 4.67 | 3.02 |
Tangible Book Value | 1,502 | 1,502 | 1,452 | 321.52 | 223.4 | 150.22 |
Tangible Book Value Per Share | 22.67 | 22.53 | 21.78 | 6.43 | 4.48 | 3.00 |
Buildings | - | 94.1 | 90.51 | 8.95 | 8.95 | 10.3 |
Machinery | - | 117.62 | 83.24 | 49.03 | 36.97 | 31.35 |
Construction In Progress | - | 1.67 | - | 56.93 | 9.16 | 0.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.